Global fibrinolytic capacity in patients with subclinical hypothyroidism.
Subclinical hypothyroidism (SH) represents the earliest stages of hypothyroidism but the benefits of detecting and treating SH are not well known. The aim of this study was to evaluate the alterations in global fibrinolytic capacity (GFC), which indicates the overall fibrinolytic activity, in patients with SH. The study group comprised of 15 patients with SH and 15 healthy controls. The GFC was significantly lower in patients with SH than in control group (p<0.002). This result suggests a relative hypercoagulable state in SH.
Guldiken
Sibel
S
Department of Endocrinology and Metabolism, Faculty of Medicine, Trakya University, Edirne, Turkey.
Demir
Muzaffer
M
Turgut
Burhan
B
Altun
Betul Ugur
BU
Arikan
Ender
E
Kara
Mujdat
M
D000328:Adult; D005260:Female; D005337:Fibrin / Q000378:metabolism*; D005338:Fibrin Fibrinogen Degradation Products / Q000378:metabolism; D005342:Fibrinolysis; D006801:Humans; D007037:Hypothyroidism / Q000097:blood*; D018709:Statistics, Nonparametric; D013972:Thyrotropin; D013974:Thyroxine / Q000097:blood; D010959:Tissue Plasminogen Activator / Q000494:pharmacology; D014284:Triiodothyronine / Q000097:blood
D005338:Fibrin Fibrinogen Degradation Products; C036309:fibrin fragment D; D014284:Triiodothyronine; D005337:Fibrin; D013972:Thyrotropin; D010959:Tissue Plasminogen Activator; D013974:Thyroxine